Related Experiment Video

Updated: Mar 23, 2026

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
08:13

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice

Published on: September 30, 2021

7.7K

Understanding cardiovascular risk in hemophilia: A step towards prevention and management

Nikolaos Sousos1, Eleni Gavriilaki1, Sofia Vakalopoulou1

  • 1Haematology Unit - Haemophilia Centre of Northern Greece, 2nd Propedeutic Department of Internal Medicine, Hippokration General Hospital of Thessaloniki, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Thrombosis Research
|April 6, 2016
PubMed

Insights

Aging individuals with hemophilia face significant cardiovascular risks. This review examines traditional, non-traditional, and treatment-related risk factors to improve cardiovascular care in this population.

Area of Science:

  • Cardiovascular Medicine
  • Hematology

Background:

  • Hemophilia care advances increase life expectancy, creating an aging population with unique health challenges.
  • Cardiovascular disease knowledge is extensive, but studies specific to hemophilia patients are limited and primarily descriptive.
  • Traditional cardiovascular risk factors appear similar or increased in hemophilia patients compared to the general population.

Purpose of the Study:

  • To review current knowledge on cardiovascular risk in hemophilia patients.
  • To focus on cardiovascular risk factors, morbidity, mortality, and management strategies.
  • To highlight the need for better understanding and prevention of cardiovascular disease in hemophilia.

Main Methods:

  • Literature review of existing studies on cardiovascular risk in hemophilia.
  • Synthesis of data on traditional, non-traditional, disease-related, and treatment-related risk factors.
  • Analysis of cardiovascular morbidity, mortality, and current management approaches.

Main Results:

  • Evidence suggests a similar or higher prevalence of traditional cardiovascular risk factors in hemophilia.
  • Non-traditional, disease-related, and treatment-related cardiovascular risk factors require further investigation.
  • Data on cardiovascular morbidity and mortality in hemophilia patients are scarce but growing.

Conclusions:

  • Improved understanding of cardiovascular risk is crucial for effective prevention and management in hemophilia.
  • Further research is needed to elucidate the specific cardiovascular risks associated with hemophilia.
  • Tailored cardiovascular prevention and management strategies are essential for the aging hemophilia population.

Keywords:
Cardiovascular mortalityCardiovascular riskHemophiliaHypertensionThrombosis

More Related Videos

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

8.2K
A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy07:24

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

2.0K

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
459
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.3K
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.7K
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
366
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
483
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
573